ATEC vs. GMED, MASI, TFX, ITGR, ATRC, IART, OFIX, SRDX, ANGO, and ARAY
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "health care equipment" industry.
Alphatec vs. Its Competitors
Globus Medical (NYSE:GMED) and Alphatec (NASDAQ:ATEC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.
In the previous week, Globus Medical had 7 more articles in the media than Alphatec. MarketBeat recorded 13 mentions for Globus Medical and 6 mentions for Alphatec. Globus Medical's average media sentiment score of 1.20 beat Alphatec's score of 1.05 indicating that Globus Medical is being referred to more favorably in the media.
Globus Medical currently has a consensus target price of $87.64, suggesting a potential upside of 51.65%. Alphatec has a consensus target price of $18.50, suggesting a potential upside of 23.09%. Given Globus Medical's higher probable upside, analysts clearly believe Globus Medical is more favorable than Alphatec.
Globus Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
Globus Medical has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500.
95.2% of Globus Medical shares are held by institutional investors. Comparatively, 66.4% of Alphatec shares are held by institutional investors. 18.5% of Globus Medical shares are held by company insiders. Comparatively, 22.8% of Alphatec shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Globus Medical has a net margin of 13.58% compared to Alphatec's net margin of -24.33%. Globus Medical's return on equity of 10.65% beat Alphatec's return on equity.
Summary
Globus Medical beats Alphatec on 13 of the 16 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
This page (NASDAQ:ATEC) was last updated on 9/17/2025 by MarketBeat.com Staff
Free ATEC Stock Alerts